# Task 3 Feedback Improvement Plan

## æ¦‚è¿°
æ ¹æ®Genmabå›¢é˜Ÿçš„feedbackï¼Œåˆ†æå“ªäº›æ”¹è¿›ç‚¹å±äºTask3çš„èŒƒå›´ï¼Œå“ªäº›ä¸å±äºã€‚

---

## âœ… å±äºTask3èŒƒå›´çš„æ”¹è¿›ç‚¹

### 1. **Clarify rare/unexpected AE detection steps** â­â­â­ (æœ€é«˜ä¼˜å…ˆçº§)

**å½“å‰çŠ¶æ€ï¼š**
- ä»£ç ä¸­æœ‰å®Œæ•´çš„è¿‡æ»¤é€»è¾‘ï¼ˆ`task3_drug_label_filter.py`ï¼‰
- ä½†ç¼ºå°‘æ¸…æ™°çš„æ–‡æ¡£è¯´æ˜å’Œæµç¨‹å›¾

**éœ€è¦æ”¹è¿›ï¼š**
- âœ… æ·»åŠ æµç¨‹å›¾ï¼š
  ```
  All AE pairs 
    â†’ Remove known label AEs (FDA drug labels)
    â†’ Remove indication-related terms
    â†’ Remove high-frequency AEs (count >= mean)
    â†’ Flag remaining rare unexpected AEs
  ```
- âœ… æ·»åŠ å…·ä½“ä¾‹å­ï¼š
  - "epcoritamab + renal impairment appeared only twice, is not on the drug label, and is below frequency thresholds (mean=3.24), so it is flagged as unexpected."
- âœ… åœ¨READMEä¸­æ¸…æ™°è¯´æ˜æ¯ä¸€æ­¥çš„è¿‡æ»¤é€»è¾‘

**å®æ–½æ–¹å¼ï¼š**
- æ›´æ–° `README.md`ï¼Œæ·»åŠ è¯¦ç»†çš„æµç¨‹å›¾ï¼ˆæ–‡æœ¬æˆ–ASCII artï¼‰
- æ·»åŠ  `DETECTION_STEPS.md` æ–‡æ¡£ï¼ŒåŒ…å«å…·ä½“ä¾‹å­
- åœ¨ä»£ç æ³¨é‡Šä¸­è¡¥å……è¯´æ˜

---

### 2. **Show how an end-user interacts with the tool** â­â­ (é«˜ä¼˜å…ˆçº§)

**å½“å‰çŠ¶æ€ï¼š**
- æœ‰ `task3_interactive_query.py` äº¤äº’æŸ¥è¯¢ç³»ç»Ÿ
- ä½†ç¼ºå°‘æ¸…æ™°çš„ä½¿ç”¨ç¤ºä¾‹å’ŒUI mock

**éœ€è¦æ”¹è¿›ï¼š**
- âœ… æä¾›æ›´æ¸…æ™°çš„ä½¿ç”¨ç¤ºä¾‹ï¼š
  ```python
  from task3_interactive_query import InteractiveAnomalyQuery
  query = InteractiveAnomalyQuery()
  result = query.check_any_combo("epcoritamab", "neutropenia")
  # Output: "RARE & UNEXPECTED" or "NOT RARE/UNEXPECTED"
  ```
- âœ… æ·»åŠ ç®€å•çš„UI mockï¼ˆPPTä¸­çš„æ¡†å›¾å’Œæµç¨‹å›¾ï¼‰ï¼š
  ```
  [Dropdown: Drug] â†’ [Dropdown: Adverse Event] â†’ [Run Button]
                                                      â†“
                                              [Output Panel]
                                              - Risk Score
                                              - Top Features
                                              - Statistical Metrics
  ```
- âœ… å±•ç¤ºè¾“å‡ºæ ¼å¼ç¤ºä¾‹ï¼š
  ```
  Drug: Epcoritamab
  Adverse Event: Neutropenia
  Status: RARE & UNEXPECTED
  Observed in: FAERS
  Count: 2
  PRR: 15.3
  IC025: 2.1
  Chi-square: 8.5
  ```

**å®æ–½æ–¹å¼ï¼š**
- æ›´æ–° `README.md`ï¼Œæ·»åŠ è¯¦ç»†çš„ä½¿ç”¨ç¤ºä¾‹
- åˆ›å»º `USAGE_EXAMPLES.md`ï¼ŒåŒ…å«å¤šä¸ªå®é™…ä¾‹å­
- åœ¨PPTä¸­æ·»åŠ UI mockå›¾

---

### 3. **Improve interpretability of the models** â­ (ä¸­ä¼˜å…ˆçº§ï¼Œéƒ¨åˆ†ç›¸å…³)

**å½“å‰çŠ¶æ€ï¼š**
- BERTä¸´åºŠç‰¹å¾åˆ†æï¼ˆ`task3_bert_clinical_features.py`ï¼‰æœ‰SHAPè¾“å‡º
- ä½†ç¼ºå°‘å¯¹SHAP/feature importanceçš„ç®€å•è§£é‡Š

**éœ€è¦æ”¹è¿›ï¼š**
- âœ… æ·»åŠ SHAP/feature importanceçš„ç®€å•è§£é‡Šï¼š
  - "A positive SHAP value means the feature pushes risk upward. For example, age > 65 increased the predicted Neutropenia risk for Patient A."
  - "A negative SHAP value means the feature reduces risk. For example, female sex reduced the predicted risk."
- âœ… æ·»åŠ æ¨¡å‹ç”¨é€”è¡¨æ ¼ï¼š
  | Model | Purpose |
  |-------|---------|
  | Isolation Forest (Rare AE Model) | Detects unexpected AE patterns that are statistically rare |
  | BERT Clinical Features | Identifies clinical risk factors (age, sex, medical history) that influence specific AEs |

**å®æ–½æ–¹å¼ï¼š**
- åœ¨ `task3_bert_clinical_features.py` çš„è¾“å‡ºä¸­æ·»åŠ è§£é‡Šæ€§æ–‡æœ¬
- åˆ›å»º `MODEL_INTERPRETATION.md` æ–‡æ¡£

---

### 4. **Add dataset and model summaries** â­ (ä¸­ä¼˜å…ˆçº§ï¼Œéƒ¨åˆ†ç›¸å…³)

**å½“å‰çŠ¶æ€ï¼š**
- ç¼ºå°‘æ•°æ®æ‘˜è¦å’Œmissingness summary

**éœ€è¦æ”¹è¿›ï¼š**
- âœ… æ·»åŠ FAERSæ•°æ®æ‘˜è¦ï¼š
  - Total drug-event pairs: X
  - Number of rare unexpected AE cases: Y
  - Percentage of complete cases: Z%
- âœ… æ·»åŠ missingness summary tableï¼š
  | Variable | Missing % | Notes |
  |----------|-----------|-------|
  | PRR | 0% | Calculated from contingency table |
  | IC025 | 0% | Calculated from contingency table |
  | Count | 0% | Direct count from FAERS |
  | Drug Name | 0% | From FAERS reports |
  | Event Name | 0% | From FAERS reports |
- âš ï¸ **æ³¨æ„**ï¼šTask3åªç”¨FAERSï¼Œä¸æ¶‰åŠJADERå’ŒEV

**å®æ–½æ–¹å¼ï¼š**
- åœ¨ `task3_improved_pipeline.py` ä¸­æ·»åŠ æ•°æ®æ‘˜è¦è¾“å‡º
- åˆ›å»º `DATA_SUMMARY.md` æ–‡æ¡£

---

### 5. **List all variables used and their data sources** â­ (ä½ä¼˜å…ˆçº§)

**å½“å‰çŠ¶æ€ï¼š**
- ç¼ºå°‘å˜é‡æ¸…å•

**éœ€è¦æ”¹è¿›ï¼š**
- âœ… åˆ—å‡ºæ‰€æœ‰ä½¿ç”¨çš„ç‰¹å¾å˜é‡ï¼š
  | Variable | Type | Data Source | Description |
  |----------|------|-------------|--------------|
  | PRR | Continuous | Calculated | Proportional Reporting Ratio |
  | IC025 | Continuous | Calculated | Information Component lower bound |
  | Chi-square | Continuous | Calculated | Chi-square statistic |
  | Count | Integer | FAERS | Number of reports for drug-event pair |
  | Drug Name | Categorical | FAERS | Drug name from reports |
  | Event Name | Categorical | FAERS | Adverse event name from reports |
- âœ… è¯´æ˜æ•°æ®æ¥æºï¼šFAERS (FDA Adverse Event Reporting System)
- âš ï¸ **æ³¨æ„**ï¼šTask3ä¸»è¦ç”¨ç»Ÿè®¡ç‰¹å¾ï¼Œä¸æ˜¯ä¸´åºŠå˜é‡ï¼ˆä¸´åºŠå˜é‡åœ¨BERTåˆ†æä¸­ï¼‰

**å®æ–½æ–¹å¼ï¼š**
- åˆ›å»º `VARIABLES_INVENTORY.md` æ–‡æ¡£
- åœ¨ `README.md` ä¸­æ·»åŠ å˜é‡è¯´æ˜

---

## âŒ ä¸å±äºTask3èŒƒå›´çš„æ”¹è¿›ç‚¹

### 1. **Make the full pipeline scalable**
- **åŸå› **ï¼šç”¨æˆ·æ˜ç¡®è¯´ä¸ç®¡äº†ï¼Œå› ä¸ºä¸è¿æ‰€æœ‰ä»»åŠ¡ï¼Œå„è‡ªå¼„å„è‡ªçš„æŒ‡ä»¤
- **Task3ç°çŠ¶**ï¼šå·²ç»æœ‰ç‹¬ç«‹çš„pipelineï¼Œå¯ä»¥å•ç‹¬è¿è¡Œ

### 2. **Strengthen the polypharmacy analysis**
- **åŸå› **ï¼šTask3ä¸»è¦æ£€æµ‹rareå’Œunexpected AEï¼Œä¸ä¸“é—¨åˆ†æpolypharmacy
- **Task3ç°çŠ¶**ï¼šBERTä¸´åºŠç‰¹å¾åˆ†æä¸­æœ‰concomitant drugsï¼Œä½†ä¸æ˜¯æ ¸å¿ƒåŠŸèƒ½

### 3. **Demonstrate handling of continuous and ordinal variables**
- **åŸå› **ï¼šTask3ä¸»è¦ç”¨ç»Ÿè®¡ç‰¹å¾ï¼ˆPRR, IC025ç­‰ï¼‰ï¼Œä¸æ˜¯ä¸´åºŠè¿ç»­å˜é‡
- **Task3ç°çŠ¶**ï¼šç»Ÿè®¡ç‰¹å¾éƒ½æ˜¯è®¡ç®—å¾—å‡ºçš„ï¼Œä¸éœ€è¦ç‰¹æ®Šå¤„ç†

### 4. **Address missing clinical variables (e.g., disease stage)**
- **åŸå› **ï¼šTask3ä¸åšä¸´åºŠå˜é‡åˆ†æï¼Œä¸»è¦å…³æ³¨ç»Ÿè®¡å¼‚å¸¸æ£€æµ‹
- **Task3ç°çŠ¶**ï¼šBERTåˆ†æä¸­æœ‰ä¸€äº›ä¸´åºŠç‰¹å¾ï¼Œä½†disease stageä¸åœ¨FAERSä¸­

### 5. **Provide database-specific analyses**
- **åŸå› **ï¼šTask3åªç”¨FAERSï¼Œä¸æ¶‰åŠJADERå’ŒEV
- **Task3ç°çŠ¶**ï¼šæ•°æ®æ¥æºå•ä¸€ï¼Œæ— æ³•åšè·¨æ•°æ®åº“æ¯”è¾ƒ

### 6. **Improve causal inference and time-to-event explanations**
- **åŸå› **ï¼šTask3ä¸åšcausal inferenceï¼Œä¸»è¦åšå¼‚å¸¸æ£€æµ‹
- **Task3ç°çŠ¶**ï¼šIsolation Forestæ˜¯unsupervised anomaly detectionï¼Œä¸æ˜¯causal model

### 7. **Biomarker integration**
- **åŸå› **ï¼šTask3ä¸æ¶‰åŠbiomarkeråˆ†æ
- **Task3ç°çŠ¶**ï¼šä¸»è¦å…³æ³¨drug-eventå…³ç³»çš„ç»Ÿè®¡å¼‚å¸¸ï¼Œä¸æ¶‰åŠbiomarkeræ•°æ®

---

## ğŸ“‹ å®æ–½ä¼˜å…ˆçº§å’Œæ—¶é—´å®‰æ’

### Phase 1: æ ¸å¿ƒåŠŸèƒ½æ–‡æ¡£åŒ–ï¼ˆå¿…é¡»å®Œæˆï¼‰
1. âœ… Clarify rare/unexpected AE detection steps
   - æ—¶é—´ï¼š2-3å°æ—¶
   - äº§å‡ºï¼šæ›´æ–°README + åˆ›å»ºDETECTION_STEPS.md

2. âœ… Show how an end-user interacts with the tool
   - æ—¶é—´ï¼š1-2å°æ—¶
   - äº§å‡ºï¼šæ›´æ–°README + åˆ›å»ºUSAGE_EXAMPLES.md + PPT UI mock

### Phase 2: å¯é€‰æ”¹è¿›ï¼ˆæœ‰æ—¶é—´å°±åšï¼‰
3. âš ï¸ Improve interpretability of the models
   - æ—¶é—´ï¼š1-2å°æ—¶
   - äº§å‡ºï¼šæ›´æ–°BERTè¾“å‡º + åˆ›å»ºMODEL_INTERPRETATION.md

4. âš ï¸ Add dataset and model summaries
   - æ—¶é—´ï¼š1-2å°æ—¶
   - äº§å‡ºï¼šæ·»åŠ æ•°æ®æ‘˜è¦è¾“å‡º + åˆ›å»ºDATA_SUMMARY.md

5. âš ï¸ List all variables used and their data sources
   - æ—¶é—´ï¼š1å°æ—¶
   - äº§å‡ºï¼šåˆ›å»ºVARIABLES_INVENTORY.md

---

## ğŸ¯ æ€»ç»“

**å¿…é¡»å®Œæˆçš„æ”¹è¿›ï¼ˆ2é¡¹ï¼‰ï¼š**
1. Clarify rare/unexpected AE detection steps
2. Show how an end-user interacts with the tool

**å¯é€‰å®Œæˆçš„æ”¹è¿›ï¼ˆ3é¡¹ï¼‰ï¼š**
3. Improve interpretability of the models
4. Add dataset and model summaries
5. List all variables used and their data sources

**ä¸éœ€è¦åšçš„æ”¹è¿›ï¼ˆ7é¡¹ï¼‰ï¼š**
- éƒ½ä¸Task3çš„æ ¸å¿ƒåŠŸèƒ½æ— å…³ï¼Œå±äºå…¶ä»–taskçš„èŒƒå›´

---

## ğŸ“ ä¸‹ä¸€æ­¥è¡ŒåŠ¨

1. å…ˆå®ŒæˆPhase 1çš„ä¸¤ä¸ªå¿…é¡»æ”¹è¿›é¡¹
2. æ ¹æ®æ—¶é—´æƒ…å†µï¼Œé€‰æ‹©æ€§å®ŒæˆPhase 2çš„æ”¹è¿›é¡¹
3. æ‰€æœ‰æ”¹è¿›éƒ½è¦æ›´æ–°åˆ°GitHubä»“åº“çš„READMEå’Œæ–‡æ¡£ä¸­

